Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-5 of 5 for your search:
Drug:
risedronate sodium
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Calcium and Cholecalciferol With or Without Conjugated Estrogens and With or Without Risedronate for the Prevention of Osteoporosis in Patients With Prostate Cancer Receiving Androgen-Ablation Therapy
Phase:
Phase III
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCCTG-N01C8
, NCI-P02-0229, N01C8, NCT00043069
2.
Phase III Randomized Study of Risedronate For Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy For Primary Breast Cancer
Phase:
Phase III
Type:
Supportive care
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCCTG-N02C1
, N02C1, NCT00054418
3.
Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Completed
Age:
Postmenopausal
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
D5392C00050
, SABRE, NCT00082277
4.
Phase III Companion Study of Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Treated on Protocol CAN-NCIC-MA27
Phase:
Phase III
Type:
Natural history/Epidemiology, Supportive care
Status:
Closed
Age:
45 and over
Sponsor:
NCI
Protocol IDs:
CAN-NCIC-MA27B
, NCIC-MA.27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, NCT00354302, MA27B
5.
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
SA-CMX-01
, NCT00426777
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute